Form 4: Cardiff Oncology CEO Buys Shares
Insider Transaction (Form 4)
Mani Mohindru, Chief Executive Officer and a Director of Cardiff Oncology, Inc., purchased 68,728 shares of common stock on July 14, 2026 for $1.46 per share.
Summary
- Open-market purchase: acquired 34,364 Common Stock at $1.46 ($50,000) on July 14, 2026; holds 59,067 after (Direct).
- Open-market purchase: acquired 34,364 Common Stock Purchase Warrant on July 14, 2026; holds 34,364 after (Direct).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $50,000, committing personal capital to the stock.
Insider Transactions
Mani Mohindru — Director, Officer (Chief Executive Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-14 | Open-market purchase | Common Stock | 34,364 | $1 | $50.0K | 59,067 |
| 2026-07-14 | Open-market purchase | Common Stock Purchase Warrant | 34,364 | — | — | 34,364 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-14 | Open-market purchase (34,364 shares) |
| 2026-07-14 | Open-market purchase (34,364 shares) |
Keywords
insider transaction, Form 4, CRDF, Cardiff Oncology, Inc., bullish, Mani Mohindru
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.